Product Information
VENLAFAXINE HCL 75 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0860 per EA under NDC 00093915701. Its NADAC has been published 323 times since Jun 17, 2020.
FDA first approved this application on Aug 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093915701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076690FDA Approved
8/3/2006
TE Code
AB
On Market Since
8/4/2006
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 75 MG TABLET has been published 323 times since Jun 17, 2020, and over the history we have for it it has declined 33.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0860 per EA |
|---|---|
| All-time high | $0.1324 (Aug 12, 2020) |
| All-time low | $0.0530 (Nov 20, 2024) |
| 52-week high | $0.0996 |
| 52-week low | $0.0789 |
| Median price | $0.0868 |
| Average price | $0.0927 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 323 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 75 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0860 per EA (NDC 00093915701), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 75 MG TABLET has declined 33.7%. It has been tracked across 323 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 75 MG TABLET?
Since Jun 17, 2020, the NADAC for VENLAFAXINE HCL 75 MG TABLET has ranged from a low of $0.0530 (Nov 20, 2024) to a high of $0.1324 (Aug 12, 2020), with a median of $0.0868 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 75 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL 75 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 75 MG TABLET?
VENLAFAXINE HCL 75 MG TABLET (NDC 00093915701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.